NCT06557486

Brief Summary

The present study aims to investigate the effect of a mindfulness-based program on perceived stress, severity of anxiety, parents'/caregivers' quality of life and their children, cortisol and IL-6 blood concentrations.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2024

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 16, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

August 16, 2024

Status Verified

August 1, 2024

Enrollment Period

2 months

First QC Date

July 30, 2024

Last Update Submit

August 13, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Perceived Stress

    To measure participants perceived stress, the Perceived Stress Scale 14 item Spanish version will be used (PSS 14). It consists of 14 items scored from 0 up to 4 (0=never, 1 = rarely 2= sometimes 3= usually 4 =almost always). The total scores on the scale can range from 0 (no stress) to 56 (extreme stress).

    baseline, two months (through study completion), and follow-up of one month

  • Cortisol levels

    The cortisol measurement will be sampled with a serum blood test. It is recommended to advise the participants to be fasted. 63 Cortisol levels fluctuate throughout the day, being highest in the morning and lowest at night.63,64 The sample will be collected between 8-9 am to get the highest cortisol.

    baseline and two months (through study completion)

Secondary Outcomes (7)

  • Severity of clinic anxiety

    baseline, two months (through study completion), and follow-up of one month

  • Sleep Quality

    baseline, two months (through study completion), and follow-up of one month

  • Quality of Life assessment

    baseline, two months (through study completion), and follow-up of one month

  • Blood pressure

    baseline, two months (through study completion), and follow-up of one month

  • Resting Heart rate

    baseline, two months (through study completion), and follow-up of one month

  • +2 more secondary outcomes

Study Arms (2)

Mindfulness-Based Stress reduction arm

EXPERIMENTAL
Behavioral: Mindfulness-Based Stress reduction

Usual care

NO INTERVENTION

Interventions

Participants assigned to the 8-week mindfulness program attended weekly 120-150 minute in-person group sessions for the entire duration. In these sessions, the instructor progressively will introduce and guide formal mindfulness practices while facilitating the sharing of experiences.

Mindfulness-Based Stress reduction arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Not having attended previously a mindfulness course
  • A score equal to or greater than 23 points at the PSS.
  • \>18 years old
  • Children \<18y with motor/physical disability due to a Neurological disorder.
  • Spanish/Catalan speaking

You may not qualify if:

  • Currently using drugs or any kind of medication related to stress, depression, anxiety or sleeping pills, such as steroid medicines.
  • Regular meditation practice (once a week in the past 12 months)
  • Diagnose of hypertension stage 2
  • Pregnancy in the case of mothers
  • Present hyperthyroidism
  • Primary adrenal insufficiency syndromes such as Cushing syndrome or Addison disease
  • Present any kind of infection or inflammation process, different from the interestingly to the present study that could differ the results

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Claudia Arumi

Lleida, 25006, Spain

Location

MeSH Terms

Conditions

Stress, Psychological

Interventions

Mindfulness-Based Stress Reduction

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 30, 2024

First Posted

August 16, 2024

Study Start

January 1, 2025

Primary Completion

March 1, 2025

Study Completion

June 1, 2025

Last Updated

August 16, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations